Circadian rhythms and rheumatoid arthritis

Area of Science:

• Chronobiology
• Immunology
• Rheumatology

Background:

• Circadian rhythms, regulated by biological clocks, govern daily physiological activities including immune functions.
• In rheumatoid arthritis (RA), circadian rhythms influence pro-inflammatory processes, with immune cell activity peaking at night.
• RA is associated with reduced nocturnal cortisol secretion, indicating impaired anti-inflammatory response during chronic stress.

Purpose of the Study:

• To explore the impact of circadian rhythms on RA pathogenesis.
• To evaluate the efficacy of chronotherapy in managing RA symptoms.
• To investigate the potential of timing medication administration to align with biological rhythms for improved treatment outcomes.

Main Methods:

• Review of existing literature on circadian rhythms in RA.
• Analysis of studies on the effects of glucocorticoids, NSAIDs, DMARDs, and methotrexate on RA, considering administration timing.
• Examination of research on the molecular mechanisms linking circadian genes and RA pathology.

Main Results:

• Exogenous glucocorticoid administration in the middle of the night (night release) demonstrated effectiveness in managing RA.
• Low-dose chronotherapy with modified-release prednisone showed positive results in RA patients.
• Nighttime administration of methotrexate showed promising results, with evidence of circadian gene upregulation and synovial fibroblast apoptosis induction.

Conclusions:

• Circadian rhythm disruption plays a significant role in RA pathogenesis, particularly concerning nocturnal immune hyperactivity.
• Chronotherapy, by optimizing drug release timing (e.g., modified-release prednisone, nighttime methotrexate), offers a promising strategy for RA treatment.
• Aligning therapeutic interventions with the body's circadian rhythms holds potential for enhanced efficacy in managing RA and other inflammatory conditions.